Krsnaa Diagnostics: Q4FY24 Result Update
29-05-2024

Steady growth continues in the quarter, the company  achieved 25 % YoY revenue growth and 28% YoY EBITDA growth on account of incremental revenues from newly launched centres & operational efficiencies. 

Few points worth noting are:

  • Krsnaa remains the biggest radiology player in the country with a total of 109 CT machines and 39 MRI machines spread across 148 centers. It has 120 Labs and 1895 collection centers under its Pathology division. It reported a Revenue growth of 25% to Rs. 619 Cr in FY24 from Rs. 487 crores in FY23. The company is working towards achieving 25% CAGR revenue growth targeting revenue of Rs.3,000 crores by FY29.
  • Reported a revenue growth of 25% to Rs. 166 crores in Q4FY24 and a slight degrowth in profit to Rs. 18.7 crores, from Rs. 18.9 Cr in Q4 FY23.
  • Krsnaa welcomed Mr. Mitesh Dave, new group CEO to head its B2C operations. Mr. Mitesh brings experience from his illustrious career in FMCG, OTC pharmaceuticals, diagnostics and single specialty hospitals. 
  • The company is also awaiting honourable High Court’s final order in the much awaited Rajasthan Tender worth Rs. 250-300 Cr.
  • It has 16 operational centers with further 57 centers under implementation in radiology segment, and 719 operational centers as well as 2594 centers under implementation in its Pathology division. Around 70% of its total centers are still under implementation.
  • The company’s revenue mix will stand at 60:40 going forward in favour of radiology with the rest 40% coming from pathology and it remains focused on expanding and leveraging their presence in underserved tier II and tier III cities, by tapping into the rising demand for quality diagnostic services in these regions. 
  • Krsnaa has also committed to enhance its centre profitability in the maturing centers and bring in operational efficiencies through process automation and cost control measures.
Disclosure: MoneyWorks4me's employees may have exposure in the securities mentioned in the above report. For detailed disclosure click here.
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.